The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Endocrine Society has achieved Accreditation with Commendation.
The Endocrine Society designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Upon completion of this educational activity, learners will be able to:
- Understand the how the therapy of hypothyroidism has evolved since the first use of thyroid gland preparations
- Describe how TSH references intervals may vary for different populations and understand the impact of TSH values on outcomes, morbidity, and mortality
- List the factors other than serum TSH values, such as T3 levels and polymorphisms in TH transporters and deiodinases, that may potentially provide information about the thyroid status of patients
- Describe the potential benefits and risks of combination therapy, and weigh these factors in order to determine whether combination therapy should be offered to patients with hypothyroidism
- Review areas with significant knowledge gaps, such as whether measuring additional thyroid analytes beyond TSH and FT4 is helpful, and whether diet/dietary supplements impact thyroid function
- Describe how patient-centered outcomes might be incorporated into the management of patients with hypothyroidism
- Appreciate the patient perspective during the treatment of hypothyroidism
This continuing medical education activity should be of substantial interest to the community of endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, trainees, nurses, physician assistants, other health care professionals and the general public who wish to broaden and update their knowledge on hypothyroidism.